A comparison trial of eight weeks versus twelve weeks of exercise program in interstitial lung diseases
- PMID: 32476917
- PMCID: PMC7170130
- DOI: 10.36141/svdld.v35i4.6830
A comparison trial of eight weeks versus twelve weeks of exercise program in interstitial lung diseases
Abstract
Background: Exercise training have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs (EPs) varies between 8-12 weeks. However, the optimal duration of EPs is still unknown. Objective: In our prospective non-controlled study, we aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD. Methods: A total of 14 patients [Age; 63(53,70) years, body mass index: 28(25,32) kg/m2, disease duration; 1.5 (1,4) years] with ILD [11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia] were included in the study. 6-minute walk test, pulmonary function test, arterial blood gas analysis, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed at before and 8 and 12 weeks after the program. Results: 6-minute walk distance, dyspnea, anxiety, depression and quality of life improved both at 8th and 12th week after EP when compared the with the initial assessment(P<0.05). When compared with 8th week; mMRC dyspnea score, 6-minute walk distance and quality of life scores significantly improved at 12th weeks (P=0.046, P=0.016, P<0.05, respectively). Conclusions: Prolonging duration of the EPs results in more improvement in functional outcomes in patients with ILD. However, it has no effect on pulmonary functions and arterial blood gas results. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 299-307).
Keywords: dyspnea; exercise; interstitial lung diseases; program duration; quality of life; six minute walk test.
Copyright: © 2018 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES.
References
-
- Travis WD, Colby TV, Koss MN. Washington, DC: American Registry of Pathology; 2002. Diffuse parenchimal lung diseases. Atlas of nontumour pathology: Non Neoplastic Disorders of the Lower Respiratory Tract, first series, fascicle 2; pp. 59–73.
-
- Baydur A. Pulmonary physiology in interstitial lung disease: Recent developments in diagnostic and prognostic implications. Curr Opin Pulm Med. 1996;2:370–375. - PubMed
-
- Bharath S, Krishnan Darcy, Marciniuk D. Weismann IM, Zeballos RJ, editors. Cardiorespiratory Responses during exercise in Interstitial Lung Disease. Clinical Exercise Testing. Prog Respir Res. Basel, Karger. 2002;32:186–99.
-
- Holland AE. Exercise limitation in interstitial lung disease-mechanisms, significance and therapeutic options. Chron Respir Dis. 2010;7:101–111. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials